Tissue-targeted regulators of complement for amelioration of human disease: rationale and novel therapeutic strategies
J Immunol. 2025 Apr 21:vkaf053. doi: 10.1093/jimmun/vkaf053. Online ahead of print. ABSTRACT The complement system is an essential part of innate immunity, and dysregulated complement is an underlying driver in many inflammatory and autoimmune diseases. Currently approved complement-focused therapeutics rely on systemic blockade of complement activation, but a major challenge with this approach is that … Read more